Clinical Trials Arena February 3, 2025
Ross Law

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial success.

This year’s Outsourcing in Clinical Trials (OCT): Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of matters including clinical trial planning, design, and execution, the importance of good data, and meeting compliance requirements for regulation, from the European Union’s artificial intelligence Act (EU AI Act) to achieving CE mark certification.

AI was a frequent theme on the agenda. The conference featured some compelling insights into the technology’s development and applicability towards helping to evolve patient care, along with several use cases of the technology in supporting...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Medical Devices, Technology
What tariffs mean for the medical device industry - and who will pay for them?
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio

Share This Article